Related Experiment Video
Updated: May 26, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4
Tao Li1, Zhiqiang Liu, Xiaoqing Hu
1Department of Biology, College of Chemistry and Life Sciences, Zhejiang Normal University, 688 Yingbin Road, Jinhua, Zhejiang, 321004, China. litao@zjnu.cn
Abstract:
GATA4 has been characterized as a crucial regulator of cardiac development and hypertrophy. Multiple signaling pathways involving MAPK contribute to GATA4 activation via direct phosphorylation. MSK and RSK are two kinase families mediating signal transduction downstream of the MAPK cascade. In this study, we investigated the effects of MSK and RSK on GATA4 activation. Overexpression of RSK2 greatly increased phosphorylation of GATA4 at Ser261. This phosphorylation enhanced its transcriptional and DNA binding activity. RSK-dependent phosphorylation of GATA4 also led to enhanced interaction with NKX2.5 and p300. Sequential phosphorylation of the ERK-RSK-GATA4 cascade and nuclear accumulation of RSK in cardiomyocytes were observed after phenylephrine treatment. Inhibition of RSK using the small molecule SL0101 abrogated GATA4 phosphorylation at Ser261, ultimately leading to a repression of fetal cardiac genes. Adenovirus-mediated overexpression of MSK1 had no direct effect on GATA4 phosphorylation but increased GATA4 expression. Together with GATA4 phosphorylation at Ser105 by ERK1/2, our findings show dual phosphorylation of GATA4 by the ERK-RSK cascade and suggest that MSK and RSK have distinct effects in PE-induced cardiac hypertrophic response.
Insights
Ribosomal S6 Kinase (RSK) directly phosphorylates GATA4, enhancing its activity in cardiac hypertrophy. This RSK-mediated GATA4 activation plays a key role in cardiac development and response to phenylephrine.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Gene Regulation
Background:
- GATA4 is a critical regulator of cardiac development and hypertrophy.
- Mitogen-activated protein kinase (MAPK) pathways activate GATA4 through phosphorylation.
- MSK (mitogen- and stress-activated protein kinase) and RSK (ribosomal S6 kinase) are key kinases downstream of MAPK.
Purpose of the Study:
- To investigate the roles of MSK and RSK in GATA4 activation and cardiac hypertrophy.
- To elucidate the specific mechanisms by which RSK influences GATA4 activity.
- To determine the impact of MSK and RSK on phenylephrine-induced cardiac responses.
Main Methods:
- Overexpression of RSK2 and MSK1 in cardiac cells.
- Analysis of GATA4 phosphorylation at Ser261 and Ser105.
- Assessment of GATA4 transcriptional and DNA binding activity.
- Investigation of GATA4 interactions with NKX2.5 and p300.
- Inhibition of RSK using the small molecule SL0101.
- Phenylephrine treatment of cardiomyocytes.
Main Results:
- RSK2 overexpression significantly increased GATA4 phosphorylation at Ser261, enhancing its transcriptional and DNA binding activity.
- RSK-dependent GATA4 phosphorylation promoted interactions with NKX2.5 and p300.
- Phenylephrine treatment induced sequential phosphorylation of the ERK-RSK-GATA4 cascade and nuclear RSK accumulation.
- RSK inhibition by SL0101 blocked GATA4 phosphorylation and repressed fetal cardiac gene expression.
- MSK1 overexpression increased GATA4 expression but did not directly affect its phosphorylation.
Conclusions:
- The ERK-RSK cascade mediates dual phosphorylation of GATA4.
- RSK plays a critical role in phenylephrine-induced cardiac hypertrophy by activating GATA4.
- MSK and RSK exhibit distinct roles in the cardiac hypertrophic response.
Related Concept Videos
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GPCRs Regulate Adenylyl Cylase Activity
Two...
GPCR Desensitization

